LLY Q4 2019 Earnings Report — Eli Lilly and Company Revenue & Financial Results | Market Cap Arena

Eli Lilly and CompanyLLY

Q4 2019 Earnings

Reported February 19, 2020

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	Q4 2019	Q3 2019	Q4 2018	QoQ Change	YoY Change
Revenue	$6.1B	$5.5B	$6.4B	11.6%	-5.0%
Op. Income	$1.6B	$1.6B	$1.6B	2.8%	0.4%
Gross Margin	79.0%	78.5%	75.2%	0.5pp	3.8pp
Net Margin	24.5%	22.9%	17.5%	1.6pp	7.0pp
EPS (Diluted)	$1.56	$1.31	$1.10	19.1%	41.8%
Free Cash Flow	$1.6B	$1.2B	$825M	40.1%	98.4%

Revenue Flow

Item	Amount
REVENUE	$6.1B
Cost of Revenue	$1.3B
GROSS PROFIT	$4.8B
R&D Expenses	$1.6B
Selling & Marketing	$0
General & Administrative	$1.6B
SG&A Expenses	$1.6B
Other Expenses	$0
Operating Expenses	$3.2B
Cost & Expenses	$4.5B
OPERATING INCOME	$1.6B
Interest Income	$13M
Interest Expense	$96M
Other Income/Expenses	$59M
INCOME BEFORE TAX	$1.7B
Income Tax Expense	$167M
Net Income from Continuing Ops	$1.5B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$1.5B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.5B
D&A	$341M
EBIT	$1.8B
EBITDA	$2.1B
EPS	$2
EPS Diluted	$2

Income Statement

Item	Amount
REVENUE	$6.1B
Cost of Revenue	$1.3B
GROSS PROFIT	$4.8B
R&D Expenses	$1.6B
Selling & Marketing	$0
General & Administrative	$1.6B
SG&A Expenses	$1.6B
Other Expenses	$0
Operating Expenses	$3.2B
Cost & Expenses	$4.5B
OPERATING INCOME	$1.6B
Interest Income	$13M
Interest Expense	$96M
Other Income/Expenses	$59M
INCOME BEFORE TAX	$1.7B
Income Tax Expense	$167M
Net Income from Continuing Ops	$1.5B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$1.5B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.5B
D&A	$341M
EBIT	$1.8B
EBITDA	$2.1B
EPS	$2
EPS Diluted	$2

Cash Flow Statement

Item	Amount
Net Income	$1.5B
Depreciation & Amortization	$341M
Stock-Based Compensation	$82M
Deferred Income Tax	$86M
Other Non-Cash Items	-$117M
Change in Working Capital	$77M
OPERATING CASH FLOW	$2.0B
Capital Expenditure	-$327M
Acquisitions (Net)	$0
Purchases of Investments	-$59M
Sales/Maturities of Investments	$132M
Other Investing Activities	$213M
NET CASH FROM INVESTING	-$41M
Net Debt Issuance	-$222M
Common Stock Repurchased	-$300M
Common Dividends Paid	-$587M
Other Financing Activities	-$5M
NET CASH FROM FINANCING	-$1.1B
FREE CASH FLOW	$1.6B
Net Change in Cash	$774M

Balance Sheet

Item	Amount
Cash & Equivalents	$2.3B
Short-Term Investments	$101M
Net Receivables	$5.5B
Inventory	$3.2B
Other Current Assets	$0
TOTAL CURRENT ASSETS	$13.7B
PP&E (Net)	$8.4B
Goodwill	$3.7B
Intangible Assets	$6.6B
Long-Term Investments	$2.0B
Tax Assets	$2.6B
Other Non-Current Assets	$2.3B
TOTAL NON-CURRENT ASSETS	$25.6B
TOTAL ASSETS	$39.3B
Account Payables	$1.4B
Short-Term Debt	$1.5B
Deferred Revenue	$0
Other Current Liabilities	$3.1B
TOTAL CURRENT LIABILITIES	$11.8B
Long-Term Debt	$13.8B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$2.2B
Other Non-Current Liabilities	$8.3B
TOTAL NON-CURRENT LIABILITIES	$24.8B
TOTAL LIABILITIES	$36.6B
Common Stock	$599M
Additional Paid-In Capital	$6.7B
Retained Earnings	$4.9B
Treasury Stock	-$61M
Accum. Other Comp. Income	-$6.5B
Other Equity	-$3.0B
TOTAL STOCKHOLDERS' EQUITY	$2.6B
Minority Interest	$92M
TOTAL EQUITY	$2.7B
TOTAL LIABILITIES & EQUITY	$39.3B
Total Debt	$15.8B
Net Debt	$13.5B